Metabolic improvement with short‐term, glucagon‐like peptide‐1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial-Reference-Cited by-同舟云学术

Metabolic improvement with short‐term, glucagon‐like peptide‐1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial

Published:2021-07-26 Issue:10 Volume:23 Page:2374-2384
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bojer Annemie Stege¹²^ORCID,Sørensen Martin Heyn¹^ORCID,Bjerre Jenny³^ORCID,Gæde Peter¹²^ORCID,Vejlstrup Niels⁴,Madsen Per Lav⁵⁶^ORCID

Affiliation:

1. Department of Cardiology and Endocrinology Slagelse Hospital Slagelse Denmark

2. Institute of Regional Health Research, Faculty of Health Sciences University of Southern Denmark Odense Denmark

3. Department of Cardiology Copenhagen University Hospital Bispebjerg Copenhagen Denmark

4. Department of Cardiology Rigshospitalet Copenhagen Denmark

5. Department of Cardiology Copenhagen University Hospital Herlev‐Gentofte Copenhagen Denmark

6. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

Funder

Hjerteforeningen

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14480

Reference36 articles.

1. Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls

2. Clinical Update: Cardiovascular Disease in Diabetes Mellitus

3. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes

4. Changes in Diastolic Dysfunction in Diabetes Mellitus Over Time

5. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the strong heart study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients With Type 2 Diabetes;Journal of the American College of Cardiology;2024-08

2. The effect of glucagon‐like peptide‐1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta‐analysis;Diabetes, Obesity and Metabolism;2024-03-26

3. The cardiovascular changes underlying a low cardiac output with exercise in patients with type 2 diabetes mellitus;Frontiers in Physiology;2024-03-20

4. Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression;Diabetes, Obesity and Metabolism;2024-03-20

5. Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials;Medicine;2024-03-15